Can Super Retail Group (ASX:SUL) reach all-time-highs again in 2024?
Super Retail Group (ASX: SUL) reached an all time high back in February 2024 after releasing unaudited results for the…
BHP Share price forecast: What’s ahead for the company in 2024 and 2025?
The stock market is always full of surprises, with BHP Group Limited (ASX: BHP) capturing plenty of attention lately. In…
Carbon neutral investing: Here’s what curious investors need to know and which stocks they might easily consider
As the world seeks to reduce carbon emissions, carbon neutral investing might be a strategy for investors to consider. But…
Best Nifty Stocks to Buy in June 2024
As we step into June 2024, the Indian stock market is truly a hotspot for investors looking to make their…
Nifty Prediction Before Election Results 2024: What to Expect on June 4
The buzz among market analysts is palpable as exit polls signal yet another win for Prime Minister Narendra Modi in…
Modi Stocks: Here are the best stocks to buy after the Indian election in 2024
Let’s take a look at so-called Modi stocks; in other words, stocks to buy after the Indian election. India may…
Director Trades: Are they a good or bad sign? Here’s what investors should read into them
Director trades – either purchases or sales – are taken by investors as a sign of confidence (or a lack…
Oracle Corporation (NYSE:ORCL): Its 50% more valuable than Adobe and double IBM! Why the high price tag?
Oracle Corporation (NYSE:OCL) is one of the world’s largest software companies. Capped at $340.1bn, it is not one of the…
Australia’s Housing Crisis is Worsening, but Savvy Investors can Benefit in 2024
The Housing Crisis is not just about problems Australia’s housing market is at a turning point. We’re seeing a serious…
Here’s why founder-led companies can be good investments, or the odd man out!
Some companies on stock exchanges are founder-led companies. For several reasons, a company being founder-led can be a sign of…
Here are the 4 best ASX stocks for June 2024
Here are the 4 best ASX stocks for June 2024! Each month, we look at the best ASX stocks of…
Dimerix (ASX:DXB) just closed a 2nd licensing deal
Dimerix (ASX:DXB) did it again ASX-listed kidney disease drug developer Dimerix (ASX: DXB) is well positioned to bring its DMX-200…
James Hardie (ASX:JHX): Things have turned glum and there could be worse to come, but are fears overblown?
James Hardie (ASX:JHX) is one of the companies many would struggle to have sympathy for. It had a tortured history…
BHP wanted to buy Anglo American, but not even A$75bn could get the deal over the line
Nearly a month since it was made clear BHP wanted to buy Anglo American, it seems the deal is off.…
Orphan Drug Designation: What is it and why is it a big deal for biotech stocks?
While most small cap health stocks dream of commercialisation, healthcare companies at an early stage get excited about achieving Orphan…